Back

Impact of DanGer Shock eligibility criteria on survival in patients with acute myocardial infarction-related cardiogenic shock: it is all about Impella?

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: The kidney and other comorbidities in cardiogenic shock Cardiogenic Shock ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Debora Sa

Hospital Dr. Nelio Mendonca, Funchal (Portugal)

7 More presentations in this session

Presentation thumbnail
The heart-kidney connection: acute kidney injury in cardiogenic shock
Doctor R. Barbosa Sousa (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Impact of early enteral nutrition on delirium prevention in patients with malnutrition concurrent with acute myocardial infarction
Doctor H. Abe (Urayasu, JP)
Abstract Slides Video
Presentation thumbnail
Interaction between renal and right ventricular function and their early prognostic relevance in patients with cardiogenic shock complicating AMI
Doctor S. Dalanbaatar (Ulaanbaatar, MN)
Abstract Slides Video
Presentation thumbnail
Association between body mass index and short-term mortality in cardiogenic shock patients supported by Impella: a multicenter retrospective study
Doctor R. Nakano (Kumamoto, JP)
Abstract Slides Video
Presentation thumbnail
Renal outcomes in patients requiring mechanical cardiac support: a comparison of micro-axial ventricular assist device to intra-aortic balloon pumping
Doctor H. Kusumoto (Takatsuki, JP)
Abstract Slides Video

Access the full session

Session thumbnail
The kidney and other comorbidities in cardiogenic shock

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Impact on mortality of a cardiogenic shock programme in a non-transplant hospital
thumbnail
Congress Presentation
The association between heart failure and cardiogenic shock in STEMI patients on admission with in-hospital mortality
thumbnail
Congress Presentation
Comparison of efficacy and safety between impella and standard care in cardiogenic shock due to acute myocardial infarction: a systematic review

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources